中国糖尿病杂志
中國糖尿病雜誌
중국당뇨병잡지
CHINESE JOURNAL OF DIABETES
2015年
8期
730-734
,共5页
病程%糖化血红蛋白%骨密度%25羟维生素D3%甲状旁腺激素%糖尿病 ,2型
病程%糖化血紅蛋白%骨密度%25羥維生素D3%甲狀徬腺激素%糖尿病 ,2型
병정%당화혈홍단백%골밀도%25간유생소D3%갑상방선격소%당뇨병 ,2형
Duration%Hemoglobin A1 c(HbA1 c)%Bone mineral density(BMD)%25-hydroxy vitamin D3[25(OH)D3 ]%Parathormone(PTH)%Diabetes mellitus,type 2
目的:观察T2DM患者钙调激素和骨密度(BMD)的变化,并对其进行相关性分析。方法选取T2DM (T2DM )患者117例和健康体检(NC)者63名。将T2DM患者分别分为病程≤10年组、病程>10年组,HbA1 c≤8%组、HbA1 c>8%组,以及BMD正常组、骨量减低组、骨质疏松(OP)组。比较各组血清25羟维生素D3[25(O H )D3)]、甲状旁腺激素(PTH)水平和腰椎(L1~L4)、股骨颈、全髋及全身BMD水平。结果(1)与NC组比较,T2DM 组25(OH)D3减低[(44.94±17.40) vs (35.57±12.30) nmol/L](P<0.01);股骨颈、全髋 BMD 下降[(0.927±0.173) vs (0.848±0.136) g/cm2;(0.934±0.140) vs (0.873±0.150) g/cm2](P<0.01或 P<0.05);PTH升高[(5.62±3.93) vs (8.50±4.15) pmol/L](P<0.01)。(2)与病程≤10年组比较,病程>10年组股骨颈和全髋BMD 下降[(0.882±0.111) vs(0.814±0.148)g/cm2;(0.908±0.139) vs (0.840±0.157)g/cm2](P<0.05);PTH 升高[(7.06±3.74) vs (10.55±9.09) pmol/L](P<0.05)。(3)与HbA1c≤8%组比较,HbA1c>8%组股骨颈、全髋 BMD 减低[(0.891±0.130) vs (0.830±0.131)g/cm2;(0.949±0.130) vs (0.832±0.161) g/cm2](P<0.05);PTH增高[(7.21±3.98) vs (9.96±8.80) pmol/L](P<0.05)。(4)T2DM 组OP和骨量减低者比例高于NC组(P<0.05),且OP组病程、HbA1c、PTH较BMD正常组和骨量减低组长或增高(P<0.05)。(5) Logistic回归分析显示,BMD与病程、HbA1c及PTH呈负相关,与25(OH)D3呈正相关。结论 T2DM患者BMD下降及OP发生率升高,以糖尿病病程长和血糖控制差者为著。
目的:觀察T2DM患者鈣調激素和骨密度(BMD)的變化,併對其進行相關性分析。方法選取T2DM (T2DM )患者117例和健康體檢(NC)者63名。將T2DM患者分彆分為病程≤10年組、病程>10年組,HbA1 c≤8%組、HbA1 c>8%組,以及BMD正常組、骨量減低組、骨質疏鬆(OP)組。比較各組血清25羥維生素D3[25(O H )D3)]、甲狀徬腺激素(PTH)水平和腰椎(L1~L4)、股骨頸、全髖及全身BMD水平。結果(1)與NC組比較,T2DM 組25(OH)D3減低[(44.94±17.40) vs (35.57±12.30) nmol/L](P<0.01);股骨頸、全髖 BMD 下降[(0.927±0.173) vs (0.848±0.136) g/cm2;(0.934±0.140) vs (0.873±0.150) g/cm2](P<0.01或 P<0.05);PTH升高[(5.62±3.93) vs (8.50±4.15) pmol/L](P<0.01)。(2)與病程≤10年組比較,病程>10年組股骨頸和全髖BMD 下降[(0.882±0.111) vs(0.814±0.148)g/cm2;(0.908±0.139) vs (0.840±0.157)g/cm2](P<0.05);PTH 升高[(7.06±3.74) vs (10.55±9.09) pmol/L](P<0.05)。(3)與HbA1c≤8%組比較,HbA1c>8%組股骨頸、全髖 BMD 減低[(0.891±0.130) vs (0.830±0.131)g/cm2;(0.949±0.130) vs (0.832±0.161) g/cm2](P<0.05);PTH增高[(7.21±3.98) vs (9.96±8.80) pmol/L](P<0.05)。(4)T2DM 組OP和骨量減低者比例高于NC組(P<0.05),且OP組病程、HbA1c、PTH較BMD正常組和骨量減低組長或增高(P<0.05)。(5) Logistic迴歸分析顯示,BMD與病程、HbA1c及PTH呈負相關,與25(OH)D3呈正相關。結論 T2DM患者BMD下降及OP髮生率升高,以糖尿病病程長和血糖控製差者為著。
목적:관찰T2DM환자개조격소화골밀도(BMD)적변화,병대기진행상관성분석。방법선취T2DM (T2DM )환자117례화건강체검(NC)자63명。장T2DM환자분별분위병정≤10년조、병정>10년조,HbA1 c≤8%조、HbA1 c>8%조,이급BMD정상조、골량감저조、골질소송(OP)조。비교각조혈청25간유생소D3[25(O H )D3)]、갑상방선격소(PTH)수평화요추(L1~L4)、고골경、전관급전신BMD수평。결과(1)여NC조비교,T2DM 조25(OH)D3감저[(44.94±17.40) vs (35.57±12.30) nmol/L](P<0.01);고골경、전관 BMD 하강[(0.927±0.173) vs (0.848±0.136) g/cm2;(0.934±0.140) vs (0.873±0.150) g/cm2](P<0.01혹 P<0.05);PTH승고[(5.62±3.93) vs (8.50±4.15) pmol/L](P<0.01)。(2)여병정≤10년조비교,병정>10년조고골경화전관BMD 하강[(0.882±0.111) vs(0.814±0.148)g/cm2;(0.908±0.139) vs (0.840±0.157)g/cm2](P<0.05);PTH 승고[(7.06±3.74) vs (10.55±9.09) pmol/L](P<0.05)。(3)여HbA1c≤8%조비교,HbA1c>8%조고골경、전관 BMD 감저[(0.891±0.130) vs (0.830±0.131)g/cm2;(0.949±0.130) vs (0.832±0.161) g/cm2](P<0.05);PTH증고[(7.21±3.98) vs (9.96±8.80) pmol/L](P<0.05)。(4)T2DM 조OP화골량감저자비례고우NC조(P<0.05),차OP조병정、HbA1c、PTH교BMD정상조화골량감저조장혹증고(P<0.05)。(5) Logistic회귀분석현시,BMD여병정、HbA1c급PTH정부상관,여25(OH)D3정정상관。결론 T2DM환자BMD하강급OP발생솔승고,이당뇨병병정장화혈당공제차자위저。
Objective To research the changes of calcium regulation hormone and bone mineral density (BMD) in type 2 diabetes mellitus (T2DM ) patients and analyze the main impact factors. Methods 117 T2DM patients (T2DM group ,M/F=52/65 ,age 40~79 years) and 63 age‐ and gender‐matched healthy people (NC group) were selected in this study. According to the course of diabetes ,blood glucose control and the value of BMD ,T2DM patients were divided into subgroups :course≤10 years ,and>10 years ;HbA1 c≤8% ,and>8% ;normal BMD ,osteopenia ,and osteoporosis (OP). Serum 25‐hydroxy vitamin D3 [25(OH)D3 ]and Parathormone (PTH) were measured and BMDs of lumbar spine (L1 ~L4 ) , femoral neck ,total hip ,and whole body were evaluated for all the subjects. Result (1)Compared with NC group ,the level of serum 25(OH)D3 and BMDs of femoral neck and total hip decreased significantly in T2DM group[ (35.57 ± 12.30)nmol/L ,(0.848 ± 0.136)g/cm2 ,(0.873 ± 0.150)g/cm2 vs(44.94 ± 17.40) nmol/L ,(0.927 ± 0.173)g/cm2 ,(0.934 ± 0.140)g/cm2 ,respectively ,P<0.01 or P<0.05)]. The level of PTH increased in T2DM group[ (8.50 ± 4.15) vs(5.62 ± 3.93)pmol/L ,P<0.01]. (2)Compared with the group duration of diabetes≤10 years ,BMD of femoral neck and total hip decreased in patients with duration of diabetes>10 years[ (0.814 ± 0.148) ,(0.840 ± 0.157) vs (0.882 ± 0.111) ,(0.908 ± 0.139) g/cm2 ,respectively ,P<0.05]. The level of PTH increased [(10.55 ± 9.09) vs (7.06 ± 3.74)pmol/L , P<0.05)]. 25(OH)D3 and total body BMD have no significant difference(P>0.05). (3)Compared with HbA1c≤8% group ,BMD of femoral neck and total hip in HbA1c> 8% group decreased [(0.830 ± 0.131) ,(0.832 ± 0.161) vs (0.891 ± 0.130) ,(0.949 ± 0.130)g/cm2 ,respectively ,P<0.05]. The level of PTH increased [(9.96±8.80) vs (7.21±3.98)pmol/L ,P<0.05]. 25(OH)D3and total body BMD have no significant difference(P> 0.05). (4)The rates of OP and osteopenia (41.03% ,47.86% ) in T2DM were higher than those in NC group (26.98% ,33.33% ) (χ2 =4.367 ,4.669 ,P<0.05). The duration of diabetes and the levels of HbA1c and PTH were longer or higher in OP group than those with normal BMD or osteopenia (P<0.05). (5)Logistic regression analysis showed that BMD negatively correlated with the duration of diabetes ,HbA1c ,and PTH (β= 0.076 ,0.213 ,0.112 ,respectively ,P< 0.05) ,and positively correlated with 25(OH)D3 (β= -0.043 ,P<0.05). Conclusion The values of BMD decreased and the incidence of OP is higher in T2DM patients ,particularly in patients with longer diabetic duration and poor glycemic control.